9-13 May 2012 • Barcelona, Spain - Estro-events.org

BARCELONA • FRIDAy, 11 MAy 2012
Scientific
cientific PProgramme
rogramme
clInIcal clInIcal InterdIscIplInary physIcs physIcs radIobIology RTT young
Microenvironment Elderly patients
in radiotherapy
departments
Quality assurance
of new techniques
and technologies
Theragnostic and imaging
in radiotherapy
The children, young
and elderly patients deal
topIcs
oF the day
TL
how to design your
study
TL
Increased number
of elderly cancer
patients: general
overview
TL
Clinical relevance
of tumour microenvironment
and
metabolism
TL
Streamlining IMRT
QA
TL
Physical and geometricaluncertainties
in functional
imaging and how to
deal with them
TL
Decision support
systems: requirements,implementation
and evaluation
TL
Current practice
and moving points:
paediatrics
08:00 – 08:40
JOInT WITH RTTs
S
Oncology safety:
learning from
experience
• Physics perspective
on incidents
• Clinician perspective
on incidents
• Incidents in related
areas: surgery
• Incidents in related
areas: medical
oncology
• Discussion
S
Radiotherapy in
elderly: where are
we aiming for in the
future
• elderly with
cancer: is it necessary
to change
the radiotherapy
protocol?
• Informing and
communicating
with elderly radiotherapy
patients
• guidelines to
treat patients
with orthopaedic
prosthesis
S
Tumour microenvironment
– novel
biology and novel
targets
• Microenvironmental
response to
phosphoinositide-3
kinase inhibition:
effects on cancer
therapy
• novel targets of
hypoxia tolerance
• Targeting vasculogenesis
to improve
radiation response
S
Dose assessment
during treatment;
towards greater
control of the dose
delivered to the
patient
• Dose reconstruction
using dynamic
log files and CbCT
• Dose reconstruction
using ePID
and CbCT
• Dose reconstruction
in tomotherapy
• Implantable MOS-
FeT dosimeters
Sa
Emerging imaging
technologies –applications
in radiation
oncology
CL, Ph, RB
• Radiomics:
advanced image
processing
approach
• new tracers
• Dual energy CT
• MRI and PeT scanner
JS
ESTRO – ESMO – ESSO
young adult
patients: the maximum
derivable or
the minimum effective
treatment
• Combined treatments
in Hodgkin
disease: the radiotherapy
optimal
dose
• breast cancer in
young women:
adjuvant therapy
and fertility considerations
• Combined treatment
rectal: young
adult patients
JS
ESTRO - PROS
Complex multimodel
approaches:
Paediatrics
• new perspectives
with protons /
particles
• new knowledge
on late effects:
second primary
cancers, cardiac
and cerebrovascular
diseases
• Technical advances
in radiotherapy for
medulloblastoma:
yesterday, today,
tomorrow
• update on neuroblastoma
08:45 – 10:00
10:00 – 10:30 COFFee bReaK
10:30 – 11:30 SeLeCTeD RanDOMIZeD TRIaLS PP PP PP
hIghLIghTS OF RANDOMISED TRIALS
11:45 – 12:15
aWaRD LeCTuRe (RegauD)
12:15 – 13:00
13:00 – 14:30 LunCH anD InDuSTRY SYMPOSIa Lunch symposium:
Education and working
around Europe
SESSIONS: TL= Teaching Lecture / S = Symposium /JS = Joint Symposium / D = Debate / PP = Proffered Papers / LI = Look Inside / EU = Session on EU Projects
DISCIPLINES: CL= Clinical / PH= Physics / BRT= Brachytherapy / RB= Radiobiology / RTT= Radiation Technology
Page 16 /// FInal announcement /// eSTRO 31 eSTRO 31 /// FInal announcement /// Page 17
clInIcal InterdIscIplInary physIcs physIcs radIobIology RTT young
S
ESTRO
contract
with the
young
JOInT
WITH
CLInICIanS
LI
Does fractionated
radiation therapy make
tumours more aggressive?
• Radiation induced
changes in cell-cell and
cell-matrix
• Vascular and metabolic
responses to tumour
irradiation
• TgFbeta: dual roles
in the response of
tumours and normal
tissues to radiation
LI
Tracking: techniques, methods,
dosimetric and QA aspects
• Motivation for real-time adaptive
therapy (what problems
are solved, how important is
this potentially, what level of
evidence is there)
• approaches for motion detection
and trajectory prediction
• Clinical commissioning and clinical
experience of real-time
adaptation
S
Imaging for treatment
assessment
• Cone beam CT based
measurement of dose
response in normal lung
• Diffusion-weighted MRI
for prediction and early
treatment assessment of
chemoradiation in head
and neck cancer
• assessment of head and
neck toxicity using CT
Sb
Emerging imaging
technologies – how
functional imaging
will impact our
practice
CL, Ph, RB
• Prostate
• brain
• Lymphoma
• Lung
S
Elderly patients’ treatment:
standards vs. feasibility
• The elderly tsunami
• Importance of age and comorbidity
for the outcome
radiotherapy in head and
neck cancer. a population
based study
• The limits in delivery of chemotherapy
in the elderly:
the breast model
• Comprehensive assessment
in elderly patients with
cancer
14:30 – 15:45
15:45 – 16:15 COFFee bReaK Moving
poster
16:15 – 17:15 S
PP S
PP D
PP PP
session
Elderly patients treatment:
Can imaging be
Why should we do pre-treat-
standards vs. feasibility
quantitative?
ment QA for IMRT when we
• Primary radiotherapy:
CL, RB
didn’t do it for conformal
head and neck
• Multi-centric
therapy?
• neoadjuvant radiotherapy:
calibration of PeT
Lower gI
• Validation of
• adjuvant and definitive
imaging
radiotherapy in elderly
• What can automa-
patients with lung cancer
tic PeT tumour volume
delineation
bring to treatment
planning?
17:30 – 18:00 aWaRD LeCTuRe (IRIDIuM) COMPanY aWaRD LeCTuReS (VaRIan, J. FOWLeR)
eSTRO SCHOOL SYMPOSIuM anD ReCePTIOn
18:00 – 19:00
SESSIONS: TL= Teaching Lecture / S = Symposium /JS = Joint Symposium / D = Debate / PP = Proffered Papers / LI = Look Inside / EU = Session on EU Projects
DISCIPLINES: CL= Clinical / PH= Physics / BRT= Brachytherapy / RB= Radiobiology / RTT= Radiation Technology